Coronary disease & ACS

Diagnostic Value of Relative Flow Reserve in Patients With Prior Coronary Artery Disease: A Post Hoc Analysis of the PACIFIC-2 Trial

Circ Cardiovasc ImagingPublished Secondary analysis of the PACIFIC-2 trial

Authors' conclusion

However, RFR does not outperform absolute hyperemic myocardial perfusion for detecting FFR-defined significant CAD in patients with prior CAD and recurrence of symptoms.

Study context

Population
Symptomatic patients with prior MI and/or PCI undergoing [15O]H2O PET perfusion imaging and invasive coronary angiography with 3-vessel fractional flow reserve (FFR)optimal cohort n = 80
Participants
187 patients
Comparison
Relative flow reserve (RFR) vs hyperemic myocardial blood flow (hMBF) by [15O]H2O PET for detecting FFR-defined significant coronary artery disease (CAD)
Primary endpoint
Diagnostic performance (C statistic) for hemodynamically significant CAD (FFR ≤0.80)
Methodological detailspost hoc analysis
  • Post hoc analysis

Primary result

As reported in the abstract

C statistic for FFR-defined significant CAD
GroupC statistic, overall cohortC statistic, optimal cohort
hMBF0.810.79
RFR0.780.82

C statistic, overall cohort

hMBF0.81
RFR0.78

C statistic, optimal cohort

hMBF0.79
RFR0.82
  • hMBF vs RFR: P = 0.288 — overall cohort
  • hMBF vs RFR: P = 0.512 — optimal cohort

Further findings

Correlation between RFR and FFR

Overall cohort
0.42
Optimal cohort
0.52
  • P<0.001 for both

Prevalence of significant CAD

Overall cohort
87 (47%)
Optimal cohort
43 (54%)

Original publication

Diagnostic Value of Relative Flow Reserve in Patients With Prior Coronary Artery Disease: A Post Hoc Analysis of the PACIFIC-2 Trial. Circ Cardiovasc Imaging. Published 30 August 2025. doi:10.1161/circimaging.125.018574

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.